10h
Zacks Investment Research on MSNBiotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & MoreIt was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
13h
RockyKanaka on MSNBull Mastiff Puppy Rushed to ER After Eating Gum—The Hidden Danger of Xylitol Poisoning in DogsAccording to this dog's owner, her pup is notorious for putting almost anything he finds in his mouth. Unfortunately this ...
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...
10h
News-Medical.Net on MSNFGFR2 identified as key driver in KRAS-mutated pancreatic cancer progressionPrecancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...
If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...
In short, Moringa powder supplements are transforming immunity by providing a natural, nutritional armor for the body.
The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.
A Leading Surgeon in New York, Shaping the Future of Cancer Care with Expertise and Compassion NEW YORK, NY, UNITED STATES, April 2 ...
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results